| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Obstetrics and Qynecology University Hospital, 8-760 14 Uppsala, Sweden
The binding of different synthetic steroids, used in hormonal contraception, to Sex Hormone Binding Globulin (SHBG)was studied by measuring their ability to displace tritiated testosterone from SHBG in a competitive protein binding system. Only 19-nortestosterone derivates had any significant ability to displace testosterone from SHBG, dnorgestrel (d-Ng) being the strongest displacer. Increasing the SHBG levels in women with previous constant plasma d-Ng levels increased these levels two-to sixfold. It is concluded that SHBG is the main carrier protein for d-Ng. The strong testosterone displacing activity of d-Ng might also explain androgenic side effects observed with d-Ng containing oral contraceptives.
This article has been cited by other articles:
![]() |
E. Johansson, V. Brache, F. Alvarez, A. Faundes, L. Cochon, S. Ranta, M. Lovern, and N. Kumar Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women Hum. Reprod., June 1, 2002; 17(6): 1472 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. B. Johansson and J. G. Krai Oral Contraceptives After Intestinal Bypass Operations JAMA, December 20, 1976; 236(25): 2847 - 2847. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |